Skip to main content
HCPCS J1951 · Level II · Part B drug

J1951: leuprolide acetate for depot suspension (Fensolvi), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1951

Billing unit
0.25 MG
Inj fensolvi 0.25 mg
ASP payment limit
$141.696
October 2026; -2.5% vs July 2026
Practitioner MUE
180
MAI 3
OPPS status
SI K
APC 9419
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1951 is the Level II code for Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg, billed per 0.25 MG. The Medicare Part B ASP payment limit for October 2026 is $141.696 per billing unit, down 2.5% from July 2026. The practitioner MUE allows up to 180 units per date of service (MAI 3), so a full 180-unit day is $25,505.28 at the current limit. Under OPPS it carries status indicator K in APC 9419. J1951 is billed in units of 0.25 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names leuprolide acetate for depot suspension: J1954 (Lutrate Depot; billed per 7.5 mg). The ASP crosswalk maps 2 NDCs to it, sold as Fensolvi by Tolmar Inc. No current Billing and Coding Article lists J1951, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1951 at $141.696 per 0.25 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $145.311 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1951
QuarterPayment limitPerCoinsurance
October 2026$141.6960.25 MG20%
July 2026$145.3110.25 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to J1951. Report the NDC in the claim's drug segment and bill the number of J1951 units that equals the quantity administered divided by 0.25 MG; the last column gives units per full package.

NDCs that crosswalk to J1951
NDCDrug nameLabelerPackage sizeBilling units / package
62935-0153-50FensolviTolmar Inc.1 × 1180
62935-0163-60FensolviTolmar Inc.1 × 1180

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J1951. For practitioners the limit is 180 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1951 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services1803 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital1803 Date of Service Edit: ClinicalPrescribing Information

MUE for J1951 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1951 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1951 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1951 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1951 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1951 carries status indicator K and is assigned to APC 9419, with a published national unadjusted payment of $141.696. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1951 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $141.70 per 0.25 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1951 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1951

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1951

What does HCPCS code J1951 describe?

J1951 is defined by CMS as "Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg". Each billing unit represents 0.25 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1951 a CPT code?

No. J1951 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as leuprolide acetate for depot suspension (Fensolvi); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1951 reports the drug itself in 0.25 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1951 in October 2026?

The ASP-based payment limit is $141.696 per 0.25 MG, with 20% beneficiary coinsurance. The July 2026 limit was $145.311. Commercial payers use their own fee schedules.

How many units of J1951 can be billed per day?

The practitioner Medically Unlikely Edit is 180 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1951?

The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Fensolvi (Tolmar Inc.). For example NDC 62935-0153-50 (package size 1) equals 180 billing units of J1951.

Does J1951 have NCCI bundling edits?

No active practitioner PTP pairs list J1951 as a column-1 or column-2 code in the v323r0 release.

J1951 vs J1954: what is the difference?

Both are HCPCS Level II codes whose descriptor names leuprolide acetate for depot suspension. What sets J1954 apart: Lutrate Depot; billed per 7.5 mg. J1951 is billed per 0.25 mg, limit $141.696, MUE 180; J1954 is billed per 7.5 mg, limit $683.86, MUE 3. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.